Remdesivir may only provide modest benefit against ‘moderate’ COVID-19
But a new study finds the drug might not be as effective for 'moderate' cases of COVID-19—patients hospitalized and perhaps needing oxygen to breathe, but not requiring a ventilator. Click here to read more.
Subscribe to the Myeloma Matters e-newsletter
We value your privacy.